For example, in breast cancer, legumain is expressed in tissue-associated macrophages (TAMs) as well as in stromal cells, and its circulating levels are significantly increased, leading to the promotion of cancer-cell proliferation and metastasis [143]. Here, LGMN is linked to breast cancer.